University of Sussex
Browse

File(s) not publicly available

Regulation of Innovative Pharmaceuticals in the EU and the US

report
posted on 2023-06-08, 00:57 authored by John Abraham, Courtney Davis
Combining theories of citizenship with documentary plus interview field methods, the proposed research will compare the regulation of innovative pharmaceuticals in the EU and the US from 1995 to 2000. It will do this: (i) by focusing on, and explaining, the inconsistencies in approvals/withdrawals of the same innovative pharmaceuticals between these European and American regulatory systems; and (ii) by considering how these regulatory systems can respond to recent, and potential future, challenges, such as the cost-effectiveness and appropriate therapeutic use of some new innovative pharmaceuticals, which command extensive medical and public demand, and the possible introduction of greater transparency and comparative effectiveness into regulatory agencies risk-benefit assessments of innovative pharmaceuticals

History

Publication status

  • Published

Publisher

Economic and Social Research Council

Department affiliated with

  • Sociology and Criminology Publications

Full text available

  • No

Peer reviewed?

  • No

Legacy Posted Date

2012-02-06

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC